Novel Protease Inhibitors Containing C-5-Modified Bis-THF and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity Against Highly Multidrug-Resistant HIV-1 With High Genetic Barrier Against the Emergence of Drug Resistance.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00372-19

Related search